Previous Article | Next Article 
Journal of Clinical Microbiology, June 2000, p. 2215-2218, Vol. 38, No. 6
Department of General
Pharmacology,1 Institute for Laboratory
Animal Science,2 and Department of
Gastroenterology and Hepatology,3 Medizinische
Hochschule Hannover, D-30625 Hannover, Germany
Received 23 August 1999/Returned for modification 15 December
1999/Accepted 27 March 2000
The aim of this study was to investigate the effect of
Helicobacter pylori on the function of gastric mucous
cells. H. pylori (104 to 107
CFU/well) was incubated with the mucin-producing gastric cell line HM02
for 12 and 24 h. Mucin synthesis and secretion were determined by
the incorporation of
D-N-[acetyl-14C]glucosamine
into intracellular and released high-molecular-weight glycoproteins.
cagA-positive, cytotoxin-producing and
non-cytotoxin-producing H. pylori strains impaired the
incorporation of
D-N-[acetyl-14C]glucosamine
into intracellular glycoproteins. Significant inhibition of mucin
synthesis was noted after 12 and 24 h of cocultivation with a
bacterial load of The human pathogen
Helicobacter pylori is the cause of antral gastritis and
peptic ulceration (11). In the human stomach, H. pylori is found within the gastric mucus layer and is primarily associated with gastric mucous cells (8, 31). The gastric mucus layer acts as a protective barrier for the gastric epithelium against luminal attack by acid and pepsin. The polymeric structure of
mucin leads to the formation of a water-insoluble gel. Bicarbonate trapped within the mucus helps the mucus layer to maintain a pH gradient between the acidic gastric lumen and the neutral epithelial surface (27). H. pylori infection is associated
with a decrease in mucus thickness (24). The bacterium is
able to elaborate protease and phospholipase (28, 34),
enzymes capable of degrading the major components of gastric mucus.
This degradation may compromise the mucus layer and facilitate reversed
diffusion of hydrogen ions.
It is not clear what distinguishes patients with H. pylori
infection who develop peptic ulceration from those who develop gastritis only. H. pylori is characterized by a high genomic
variability which forms the basis for interstrain differences in
pathogenic potential (4). For instance, the vacuolating
cytotoxin VacA is encoded by a gene occurring in multiple alleles that
may or may not affect the secretion of a more or less active gene
product (1). A second marker for pathogenicity is the
product of cagA, which is usually coexpressed with
vacA (32). Cytotoxin-producing strains seem to
cause ulcers more than non-cytotoxin-producing strains (9,
14).
The aim of this work was to investigate whether H. pylori
directly affects mucus synthesis and secretion in a cellular in vitro
system and, if so, whether there are differences between different
H. pylori strains.
(Part of this work has been presented at the 100th meeting of the
American Gastroenterological Association, Orlando, Fla., and has been
published in abstract form [Gastroenterology, 116:A354, 1999].)
H. pylori culture.
Nine clinical isolates
of H. pylori were used: the cagA-negative,
non-cytotoxin-producing strains HP01, HP04, and HP85; the cagA-positive, non-cytotoxin-producing strains HP05, HP83,
and HP84; and the cagA-positive, cytotoxin-producing
strains HP64, HP57, and HP87. The presence of cagA mRNA in
the H. pylori strains was analyzed by reverse
transcription-PCR using the primers (5' GAT AAC AGG CAA GCT TTT GAG 3'
and 5' CTG CAA AAG ATT GTT TGG CAG 3') and incubation conditions
described by Tummuru et al. (32). The presence of the
vacuolating toxin was determined by incubation of HM02 cells with
concentrated supernatants from H. pylori broth medium as
described by Cover et al. (10). Bacteria were grown on blood
agar plates under microaerophilic conditions for 2 days at 37°C.
Bacteria were harvested in phosphate-buffered saline solutions. For
estimation of the desired final bacterial numbers, optical densities at
600 nm were measured and were correlated to viable CFU. Comparative
experiments were conducted with Campylobacter jejuni (ATCC
33560; American Type Culture Collection, Manassas, Va.).
Cell culture and cocultivation experiments.
HM02 cells,
which were derived from a human well-differentiated mucus-producing
gastric carcinoma, were used in all experimental protocols. Previous
studies have shown that H. pylori specifically adheres to
HM02 cells and that this cell line provides a suitable in vitro model
for the study of the interaction of H. pylori and the
gastric epithelium (33). Cells were seeded at a density of
4 × 105 cells/well in six-well plastic plates
(Greiner, Nürtingen, Germany), incubated overnight, and washed in
RPMI 1640 medium before incubation with H. pylori
(104 to 107 CFU/well; total volume, 2 ml).
Cocultivation was performed for up to 24 h in RPMI 1640 medium
supplemented with 10% heat-inactivated fetal calf serum (FCS) at
37°C in a humidifed atmosphere of 5% CO2 in air.
Uninoculated RPMI 1640 medium was used as a control. All tests were
performed in triplicate.
Determination of glycoprotein synthesis and secretion.
Intracellular and released mucins were quantified by the rates of
incorporation of
N-[acetyl-14C]glucosamine
([14C]GlcNAc) into [14C]trichloroacetic
acid-phosphotungstic acid (TCA-PTA)-precipitable intracellular and
secreted proteins. Experiments began 24 h after seeding, when the
cells had formed a monolayer. The monolayers were washed, and 0.5 µCi
of N-[acetyl-14C]glucosamine per ml
and various amounts of H. pylori were added. After 12 and
24 h, the medium was removed and the monolayer was rinsed with
RPMI 1640 medium. The cells and collected culture medium were
precipitated with ice-cold TCA-PTA (final concentrations, 12.5 and
1.25%, respectively) and left at 4°C overnight. The samples were
then centrifuged (10,000 × g). The pellets were
resuspended, washed three times with TCA-PTA, and subsequently
dissolved in 1 M KOH, and counts were determined.
Isolation of HMG.
HM02 cells were incubated for 24 h
with the vacA- and cagA-positive strains HP87,
HP57, and HP64. Cells were harvested and disrupted by sonication, and
the 2,000 × g supernatant of the cell sonicate was
submitted to gel filtration on a Sepharose CL-4B column (0.9 by 30 cm;
Pharmacia) and eluted with 10 mM phosphate-buffered saline (pH 8.0).
The carbohydrate content of high-molecular-weight glycoproteins (HMG)
in the voided-volume fractions (fractions 8 to 14) was quantified by
the periodic acid-Schiff stain (PAS) reaction (12); the HMG
content was quantified by the Bradford assay (6).
Assessment of cell integrity.
Cytotoxicity was evaluated by
trypan blue exclusion and release of lactate dehydrogenase (LDH).
Gastric cell number and viability were determined with a hemocytometer
by trypan blue (0.04%) exclusion. LDH was determined by a
spectrophometric assay with pyruvate and NADH as substrates
(18).
Statistics.
Results are expressed as means ± standard
errors of the means (SEM). To determine statistical significance, we
used Student's t test for paired or unpaired comparisons.
Significance was accepted at a P value of <0.05.
Effect of H. pylori on mucin synthesis and
secretion.
The ability of HM02 cells to synthesize and to secrete
mucin HMG was studied by determination of the rates of incorporation of
[14C]GlcNAc into acid-insoluble proteins. Basal rates of
incorporation of [14C]GlcNAc into cellular mucin were
4,793 ± 1,066 and 7,725 ± 1,231 cpm/well after 12 and
24 h of incubation, respectively. The cell numbers per well were
(0.39 ± 0.02) × 106 and (0.92 ± 0.08) × 106, respectively.
[14C]GlcNAc-labeled mucins in the culture medium
represented 5.8 to 10.6% of the intracellular labeled mucins.
0095-1137/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Role of vacA and cagA in
Helicobacter pylori Inhibition of Mucin Synthesis in Gastric
Mucous Cells
ABSTRACT
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
105 bacteria (bacterium/cell ratio = 0.25). The cagA-positive, cytotoxin-producing strains
(HP64, HP57, and HP87) caused significantly stronger inhibition of
intracellular mucin synthesis than the cagA-positive,
non-cytotoxin-producing strains (HP05, HP83, and HP84). The
cagA-negative, non-cytotoxin-producing strains (HP01, HP04,
and HP85) did not affect intracellular mucin synthesis. The results
indicate that H. pylori directly impairs mucin synthesis in
gastric mucous cells and that cytotoxic cagA-positive strains cause more profound inhibition of mucin synthesis. We suggest
that the increased inhibitory effect of cagA-positive, cytotoxin-producing strains on mucin synthesis can be considered one
possible factor responsible for the increased risk of developing peptic
ulceration with these H. pylori strains.
INTRODUCTION
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
MATERIALS AND METHODS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
RESULTS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
105 bacteria (bacterium/cell ratio = 0.25). A
smaller bacterial load (104 bacteria) did not significantly
alter mucin synthesis. The amount of labeled mucins recovered from the
culture medium of HM02 cells remained unchanged. The
cagA-positive, cytotoxin-producing strains caused stronger
inhibition of intracellular mucin synthesis than the
cagA-positive, non-cytotoxin-producing strains.
Significantly different effects were noted at bacterial loads of
106 bacteria (cytotoxin-negative strains, 
33.5% ± 4.6%; cytotoxin-positive strains, 56.3% ± 4.4%) and
107 bacteria (cytotoxin-negative strains, 33.5% ± 4.7%; cytotoxin-positive strains, 50.0% ± 7.9%) (Fig.
1). Similar effects were observed at the
end of the 24-h incubation period. The cytotoxin-negative strains at
105, 106, and 107 bacteria/ml
reduced [14C]GlcNAc incorporation by 22.5% ± 7.7%,
31.2% ± 7.6%, and 26.7% ± 11%, respectively; the
cytotoxin-positive strains reduced intracellular incorporation rates by
55.3% ± 11%, 56.7% ± 8.4%, and 56.3% ± 11%, respectively
(P < 0.05 relative to values for cytotoxin-negative strains at 105, 106, and 107
bacteria). In contrast, the cagA-negative,
non-cytotoxin-producing strains (HP01, HP04, and HP85) did not affect
intracellular mucin synthesis (data not shown).
View larger version (16K):
[in a new window]
FIG. 1.
Effect of increasing amounts of
cagA-positive, non-cytotoxin-producing H. pylori
strains (filled squares) and cytotoxin-producing H. pylori
strains (filled circles) on mucin synthesis (open squares) and mucin
secretion (open circles) of HM02 cells. HM02 cells were incubated for
12 h with H. pylori (105 to 107
CFU/well) in RPMI 1640 medium supplemented with 10% FCS and 0.5 µCi
of [14C]GlcNAc per ml. Mucin synthesis and secretion were
determined as described in Materials and Methods. Data are means ± SEM from three experiments with strains HP05, HP83, and HP84 and
strains HP64, HP57, and HP87. C, control. P values were
<0.05 in comparison with the appropriate control (*) and with
non-cytotoxin-producing strains (++). Similar data were obtained after
24 h of incubation.
Isolation of intracellular HMG from H. pylori-treated
HM02 cells.
The vast majority of PAS-positive material in HM02
cells eluted in the voided volume (fractions 8 to 14) after gel
chromatography, indicating the presence of glycoproteins with a
molecular mass of 2 × 106 Da (HMG) in the cells. In
agreement with the tracer studies, HP87, HP57, and HP64 impaired the
carbohydrate content of HMG. At bacterial loads of 105,
106, and 107, PAS-positive material was
significantly decreased to 74.6% ± 8%, 73.6% ± 7%, and 62.0% ± 13% the level in controls. In contrast, protein content in the
PAS-positive material was increased to 110% ± 11%, 159% ± 43%,
and 167% ± 28% the level in controls (P < 0.05 for
107 bacteria) (data not shown).
Effect of H. pylori on cell viability. Cocultivation of HM02 cells with H. pylori (cagA-positive, non-cytotoxin-producing and cytotoxin-producing strains) for 24 h was not associated with a reduction in gastric cell count. At the highest bacterial load (107/ml), cell counts were (0.92 ± 0.03) × 106 (cytotoxin-negative strains) and (0.82 ± 0.05) × 106 (cytotoxin-positive strains) cells/well, respectively. Likewise, LDH release did not increase, indicating that H. pylori did not exert a major cytotoxic effect.
Effect of C. jejuni on mucin synthesis and
secretion.
In contrast to H. pylori, C. jejuni significantly stimulated the incorporation of
[14C]GlcNAc into intracellular mucins and the release of
labeled mucins into the culture medium during the 12-h (Fig.
2) and 24-h (data not shown) incubation
periods.
|
| |
DISCUSSION |
|---|
|
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
|
|---|
Under normal conditions, the gastric mucus layer acts as a protective barrier for the gastric epithelium against luminal attack by acid, pepsin, and exogenous damaging agents. Available data indicate that H. pylori undermines the integrity of the mucus layer, i.e., accelerates mucus degradation, perhaps through lipolytic and proteolytic activities (20, 22, 28, 34). However, the importance of proteolytic enzymes in the pathophysiology of H. pylori remains controversial (3, 26).
The results reported in this study indicated that
cagA-positive, cytotoxin-producing and
non-cytotoxin-producing H. pylori strains impaired mucin
synthesis in gastric mucous cells. In contrast, cagA-negative, non-cytotoxin-producing strains did not
affect mucin synthesis. Significant alterations of intracellular mucins were found after incubation for 12 h with 105
bacteria (bacterium/cell ratio = 0.25). None of the H. pylori strains affected the baseline mucin secretion of HM02
cells. In contrast to these results, Micots et al. (21)
reported a modest inhibition of mucin secretion from colonic Cl.16E
cells incubated with H. pylori. The reasons for this
discrepancy may be attributed to the different cellular models used for
testing (gastric cells versus colonic cells). However, the baseline
mucin secretion of HM02 cells is rather low. Therefore, changes in the
amount of secreted radioactive mucins may be detected only after
long-term incubation.
The intracellular synthesis of mucin proceeds through the steps of ribosomal synthesis of core peptides, formation of sugar nucleotides, addition of N-acetylgalactosamine to serine or threonine residues in the endoplasmic reticulum and/or Golgi complex, and formation of oligosaccharide cores in the Golgi system. The oligosaccharide cores are then elongated, producing chains of from 2 to 20 sugars in length that have a variety of linear or branched patterns. Finally, other posttranslational modifications, such as sulfation, complete the molecule. The mucins are packed in secretory vesicles and are ready for migration to the cell apex (15).
vacA induces acidic vacuoles in the cytoplasm of eukaryotic cells. The membranes of cytotoxin-induced vacuoles react with anti-rab 7 antibodies, suggesting that these vacuoles are derived, at least in part, from late endosomes (23). Such compartments are crucial crossroads in the complex network of intracellular membrane traffic in eukaryotic cells. Garner and Cover (16) noted that vacA interacts with endocytic vesicles, and Satin et al. (25) have recently shown that vacA modifies the intracellular sorting of endogenous proteins. Based on these observations, we suggest that the increased activity of cytotoxic H. pylori strains on mucin synthesis may be caused by the interaction of vacA with the intracellular processing or sorting of glycoproteins. This hypothesis is supported by the finding that exposure of HM02 cells to cytotoxic H. pylori strains induces the formation of "immature" glycoproteins; i.e. the bacterium decreases carbohydrate content and increases protein content in glycoproteins.
The fucosylated blood group antigens Lewis b and H-1 mediate the adherence of H. pylori to gastric mucous cells (5, 13). cagA-positive strains show about a fivefold higher density of bacterial cells in the gastric antrum than cagA-negative strains (2). Ilver et al. (19) have provided evidence that the presence of cagA is associated with bacterial binding to the Lewis b antigen. The cagA gene encodes a protein involved in the export of bacterial virulence factors (7). Based on these observations, we propose that cagA-mediated adherence of H. pylori to mucous cells may play a critical role in the delivery to HM02 cells of bacterial factors that alter mucin synthesis. However, the exact biochemical mechanism of the effect of cagA on mucin synthesis remains unclear.
Much evidence indicates that H. pylori vacA- and cagA-positive strains are endowed with an increased pathogenic ulcerative potential. Purified vacA induces ulceration in the stomach of mice (30), and vacuolating cytotoxic bacteria are more often isolated from patients with peptic ulcer disease (9, 14, 29). Our data demonstrate that cytotoxic cagA-positive H. pylori strains induce amore profound inhibition of mucin synthesis than cagA-positive, non-cytotoxin-producing strains, whereas cagA-negative, non-cytoxin-producing strains do not affect mucin synthesis. A decrease in the synthesis of glycoproteins and changes in gastric mucin structure accompany the development of gastritis and are prominent features in the etiology of peptic ulcers (17). Recognizing that the results of our in vitro study cannot be directly extrapolated to the interaction of H. pylori with mucin synthesis in vivo, the findings suggest that the inhibitory effect of cagA-positive, cytotoxin-producing strains on mucin synthesis can be considered one possible factor responsible for the increased risk of developing peptic ulceration with these H. pylori strains.
| |
ACKNOWLEDGMENTS |
|---|
This work was supported by a grant from Deutsche Forschungsgemeinschaft (Sonderforschungsbereich 280, TP A7).
We thank U. Staar for skillful technical assistance.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Institut für Pharmakologie, Medizinische Hochschule Hannover, Carl-Neuberg-Str. 1, D-30625 Hannover, Germany. Phone: 49/511-5322951. Fax: 49/511-5322794. E-mail: stanke.annette{at}mh-hannover.de.
| |
REFERENCES |
|---|
|
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
|
|---|
| 1. |
Atherton, J. C.,
P. Cao,
R. M. Peek,
M. K. Tummuru,
M. J. Blaser, and T. L. Cover.
1995.
Mosaicism in vacuolating cytotoxin alleles of Helicobacter pylori. Association of specific vacA types with cytotoxin production and peptic ulceration.
J. Biol. Chem.
270:17771-17777 |
| 2. | Atherton, J. C., R. M. Peek, K. T. Tham, G. I. Perez-Perez, and M. J. Blaser. 1994. Quantitative culture of Helicobacter pylori in the gastric antrum: association of bacterial density with duodenal ulcer status and infection with cagA positive strains, and negative association with serum IgG levels. Am. J. Gastroenterol. 89:1322. |
| 3. | Baxter, A., C. J. Campbell, D. M. Cox, C. J. Grinham, and J. E. Pendlebury. 1989. Proteolytic activities of human Campylobacter pylori and ferret gastric Campylobacter-like organisms. Biochem. Biophys. Res. Commun. 163:1-7[CrossRef][Medline]. |
| 4. | Blaser, M. J. 1996. Role of vacA and the cagA locus of Helicobacter pylori in human disease. Aliment. Pharmacol. Ther. 10(Suppl. 1):73-77[Medline]. |
| 5. |
Boren, T.,
P. Falk,
K. A. Roth,
G. Larson, and S. Normark.
1993.
Attachment of Helicobacter pylori to human gastric epithelium mediated by blood group antigens.
Science
262:1892-1895 |
| 6. | Bradford, M. M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:248-254[CrossRef][Medline]. |
| 7. |
Censini, S.,
C. Lange,
Z. Xiang,
J. E. Crabtree,
P. Ghiara,
M. Borodovsky,
R. Rappuoli, and A. Covacci.
1996.
cag, a pathogenicity island of Helicobacter pylori, encodes type I-specific and disease-associated virulence factors.
Proc. Natl. Acad. Sci. USA
93:14648-14653 |
| 8. | Chen, X. G., P. Correa, J. Offerhaus, E. Rodriguez, F. Janney, E. Hoffmann, J. Fox, F. Hunter, and S. Diavolitsis. 1986. Ultrastructure of the gastric mucosa harbouring Campylobacter like organisms. Am. J. Clin. Pathol. 86:575-582[Medline]. |
| 9. |
Cover, T. L.,
C. P. Dooly, and M. J. Blaser.
1990.
Characterization of a human serologic response to proteins in Helicobacter pylori broth culture supernatants with vacuolizing cytotoxin activity.
Infect. Immun.
58:603-610 |
| 10. |
Cover, T. L.,
W. Puryear,
G. I. Perez-Perez, and M. J. Blaser.
1991.
Effect of urease on HeLa cell vacuolation induced by Helicobacter pylori cytotoxin.
Infect. Immun.
59:1264-1270 |
| 11. | Dunn, B. E., H. Cohen, and M. J. Blaser. 1997. Helicobacter pylori. Clin. Microbiol. Rev. 10:720-741[Abstract]. |
| 12. | Enss, M. L., H. Grosse-Siestrup, U. Schmitt-Wittig, and K. Gärtner. 1992. Changes in colonic mucins of germfree rats in response to the introduction of a "normal" rat microbial flora. Rat colonic mucin. J. Exp. Anim. Sci. 35:110-119[Medline]. |
| 13. |
Falk, P.,
K. A. Roth,
T. Boren,
U. Westblom,
J. I. Gordon, and S. Normark.
1993.
An in vitro adherence assay reveals that Helicobacter pylori exhibits cell lineage-specific tropism in the gastric epithelium.
Proc. Natl. Acad. Sci. USA
90:2035-2039 |
| 14. |
Figura, N.,
P. Guglielmetti,
A. Rossolini,
A. Barberi,
G. Cusi,
R. A. Musmann,
M. Russi, and S. Quaranta.
1989.
Cytotoxin production of Campylobacter pylori strains isolated from patients with peptic ulcers and from patients with chronic gastritis only.
J. Clin. Microbiol.
27:225-226 |
| 15. | Forstner, J. F., and G. G. Forstner. 1994. Gastrointestinal mucus, p. 1255-1283. In L. R. Johnson (ed.), Physiology of the gastrointestinal tract. Raven Press, New York, N.Y. |
| 16. | Garner, J. A., and T. L. Cover. 1996. Binding and internalization of the Helicobacter pylori vacuolating cytotoxin by epithelial cells. Infect. Immun. 64:4179-4203. |
| 17. | Glass, G. B. J., and B. L. Slomiany. 1977. Derangements of biosynthesis, production and secretion of mucus in gastrointestinal injury and disease, p. 311-347. In M. Elstein, and D. V. Parke (ed.), Mucus in health and disease. Plenum Press, New York, N.Y. |
| 18. |
Howell, B. F.,
S. McCune, and R. Schaffer.
1979.
Lactate-to-pyruvate or pyruvate-to-lactate assay for lactate dehydrogenase: a re-examination.
Clin. Chem.
25:269-272 |
| 19. |
Ilver, D.,
A. Arnqvist,
J. Ögren,
I. M. Frick,
D. Kersulyte,
E. T. Incecik,
D. E. Berg,
A. Covacci,
L. Engstrand, and T. Boren.
1998.
Helicobacter pylori adhesin binding fucosylated histo-blood group antigens revealing by retagging.
Science
279:373-377 |
| 20. |
Langton, S. R., and S. D. Cesareo.
1992.
Helicobacter pylori associated phospholipase A2 activity: a factor in peptic ulcer production?
J. Clin. Pathol.
45:221-224 |
| 21. |
Micots, I.,
C. Augeron,
C. L. Laboisse,
F. Muzeau, and F. Megraud.
1993.
Mucin exocytosis: a major target for Helicobacter pylori.
J. Clin. Pathol.
46:241-245 |
| 22. | Ottlecz, A., J. J. Romero, S. L. Hazell, D. Y. Graham, and L. M. Lichtenberger. 1993. Phospholipase activity of Helicobacter pylori and its inhibition by bismuth salts: biochemical and biophysical studies. Dig. Dis. Sci. 38:2071-2080[CrossRef][Medline]. |
| 23. | Papini, E., M. De Bernard, E. Milia, M. Bugnoli, M. Zerial, R. Rappuoli, and C. Montecucco. 1994. Cellular vacuoles induced by Helicobacter pylori originate from late endosomal compartments. Proc. Natl. Acad. Sci. USA 9117:9720-9724. |
| 24. | Sarosiek, J., B. J. Marshall, D. A. Peura, S. Hoffman, T. Feng, and R. W. McCallum. 1991. Gastrointestinal mucus gel thickness in patients with Helicobacter pylori: a method for assessment of biopsy specimens. Am. J. Gastroenterol. 86:729-734[Medline]. |
| 25. |
Satin, B.,
N. Norais,
J. Telford,
R. Rappuoli,
M. Murgia,
C. Montecucco, and E. Papini.
1997.
Effect of Helicobacter pylori vacuolating toxin on maturation and extracellular release of procathepsin D and on epidermial growth factor degradation.
J. Biol. Chem.
272:25022-25028 |
| 26. | Sidebotham, R. L., J. J. Batten, Q. N. Karim, J. Spencer, and J. H. Baron. 1991. Breakdown of gastric mucus in presence of Helicobacter pylori. J. Clin. Pathol. 36:52-57. |
| 27. | Silen, W. 1987. Gastric mucosal defense and repair, p. 1055-1069. In L. R. Johnson (ed.), Physiology of the gastrointestinal tract. Raven Press, New York, N.Y. |
| 28. | Slomiany, B. L., J. Bilski, J. Sarosiek, V. L. N. Murty, B. Dworkin, K. VanHorn, J. Zielenski, and A. Slomiany. 1987. Campylobacter pyloridis degrades mucin and undermines gastric mucosal integrity. Biochem. Biophys. Res. Commun. 144:307-314[CrossRef][Medline]. |
| 29. | Tee, W., J. R. Lambert, M. Pegorer, and B. Dwyer. 1995. Cytotoxin production by Helicobacter pylori is more common in peptic ulcer disease. J. Clin. Microbiol. 33:1203-1205[Abstract]. |
| 30. |
Telford, J. L.,
P. Ghiara,
M. Dell'Orco,
M. Comanducci,
D. Burroni,
M. Bugnoli,
M. F. Tecce,
S. Censini,
A. Covacci, and Z. Xiang.
1994.
Gene structure of the Helicobacter pylori cytotoxin and evidence of its key role in gastric disease.
J. Exp. Med.
179:1653-1658 |
| 31. |
Thomsen, L. L.,
J. B. Gavin, and C. Tasman-Jones.
1990.
Relation of Helicobacter pylori to the human gastric mucosa in chronic gastritis of the antrum.
Gut
31:1230-1236 |
| 32. |
Tummuru, M. K.,
T. L. Cover, and M. J. Blaser.
1993.
Cloning and expression of a high-molecular-mass major antigen of Helicobacter pylori: evidence of linkage to cytotoxin production.
Infect. Immun.
61:1799-1809 |
| 33. | Wagner, S., W. Beil, U. E. H. Mai, C. Bokemeyer, H. J. Meyer, and M. P. Manns. 1994. Interaction between Helicobacter pylori and human gastric epithelial cells in culture: effect of antiulcer drugs. Pharmacology 49:226-237[Medline]. |
| 34. | Weitkamp, J. H., G. I. Perez-Perez, G. Bode, P. Malfertheiner, and M. J. Blaser. 1993. Identification and characterization of Helicobacter pylori phospholipase C activity. Zentbl. Bakteriol. 280:11-27. |
Journal of Clinical Microbiology, June 2000, p. 2215-2218, Vol. 38, No. 6
0095-1137/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Henriksnas, J., Phillipson, M., Storm, M., Engstrand, L., Soleimani, M., Holm, L.
(2006). Impaired mucus-bicarbonate barrier in Helicobacter pylori-infected mice. Am. J. Physiol. Gastrointest. Liver Physiol.
291: G396-G403
[Abstract] [Full Text] -
Sumie, A., Yamashiro, T., Nakashima, K., Nasu, M., Watanabe, M., Nishizono, A.
(2001). Comparison of Genomic Structures and Antigenic Reactivities of Orthologous 29-Kilodalton Outer Membrane Proteins of Helicobacter pylori. Infect. Immun.
69: 6846-6852
[Abstract] [Full Text]
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»